Zai Lab Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ZLAB Nasdaq 2830 www.zailaboratory.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zai Lab Limited

What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates - Nov 7th, 2025 11:58 am
Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Nov 6th, 2025 12:08 pm
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates - Nov 6th, 2025 5:00 am
Zai Lab Announces Participation in Investor Conferences in November and December 2025 - Oct 31st, 2025 5:30 am
Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline - Oct 30th, 2025 2:11 pm
Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - Oct 30th, 2025 8:38 am
Asian Equities Traded in the US as American Depositary Receipts End Week Higher in Friday Trading - Oct 24th, 2025 8:39 am
Zai Lab Says Potential Lung Cancer Treatment Shows High Response Rate in Updated Phase 1 Data - Oct 24th, 2025 8:20 am
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study - Oct 24th, 2025 7:00 am
Could Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrative? - Oct 15th, 2025 9:12 am
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announcement - Oct 15th, 2025 8:10 am
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 - Oct 15th, 2025 5:30 am
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - Oct 13th, 2025 10:02 am
Zai Lab Limited (ZLAB): A Bull Case Theory - Sep 16th, 2025 10:32 am
China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order - Sep 10th, 2025 1:55 pm
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Sep 10th, 2025 8:37 am
Institutional investors may overlook Zai Lab Limited's (NASDAQ:ZLAB) recent US$260m market cap drop as long-term gains remain positive - Sep 6th, 2025 8:07 am
Asian Equities Traded in the US as American Depositary Receipts Decline Slightly in Thursday Trading - Sep 4th, 2025 8:35 am
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong - Sep 1st, 2025 6:00 pm
Zai Lab Announces Participation in Investor Conferences in September 2025 - Aug 28th, 2025 5:30 am